Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew S Gentry

Showing results (51-60 of 125) with videos related to

Pageof 13
Sort By:
Molecular and Cellular Biology|July 16, 2014
HUWE1 is a molecular link controlling RAF-1 activity supported by the Shoc2 scaffoldEun Ryoung Jang, Ping Shi, Jamal Bryant, et al.
Current Opinion in Neurology|August 28, 2023
Current avenues of gene therapy in Pompe diseaseCarmen Leon-Astudillo, Prasad D Trivedi, Ramon C Sun, et al.
Journal of Clinical Medicine|January 18, 2020
Clear Cell Adenocarcinoma of the Urinary Bladder Is a Glycogen-Rich Tumor with Poorer PrognosisZhengqiu Zhou, Connor J Kinslow, Peng Wang, et al.
Journal of Clinical Medicine|February 17, 2019
Clinical Features, Survival and Prognostic Factors of Glycogen-Rich Clear Cell Carcinoma (GRCC) of the Breast in the U.S. PopulationZhengqiu Zhou, Connor J Kinslow, Hanina Hibshoosh, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2010
Structural basis for the glucan phosphatase activity of Starch Excess4Craig W Vander Kooi, Adam O Taylor, Rachel M Pace, et al.
Elife|October 25, 2017
What's in a name?Michael D Schaller, Gary McDowell, André Porter, et al.
Plos One|September 3, 2011
Laforin, a dual specificity phosphatase involved in Lafora disease, is present mainly as monomeric form with full phosphatase activityVikas V Dukhande, Devin M Rogers, Carlos Romá-Mateo, et al.
Human Molecular Genetics|December 22, 2011
Laforin and malin knockout mice have normal glucose disposal and insulin sensitivityAnna A DePaoli-Roach, Dyann M Segvich, Catalina M Meyer, et al.
Epilepsy Research|July 25, 2018
A novel EPM2A mutation yields a slow progression form of Lafora diseaseMaria Adelaida Garcia-Gimeno, Pilar Natalia Rodilla-Ramirez, Rosa Viana, et al.
Epilepsy & Behavior : E&B|May 4, 2021
The 6th International Lafora Epilepsy Workshop: Advances in the search for a cureKia H Markussen, Jessica K A Macedo, María Machío, et al.
Pageof 13

Showing results (51-60 of 125) with videos related to

Sort By:
Pageof 13
Molecular and Cellular Biology|July 16, 2014
HUWE1 is a molecular link controlling RAF-1 activity supported by the Shoc2 scaffoldEun Ryoung Jang, Ping Shi, Jamal Bryant, et al.
Current Opinion in Neurology|August 28, 2023
Current avenues of gene therapy in Pompe diseaseCarmen Leon-Astudillo, Prasad D Trivedi, Ramon C Sun, et al.
Journal of Clinical Medicine|January 18, 2020
Clear Cell Adenocarcinoma of the Urinary Bladder Is a Glycogen-Rich Tumor with Poorer PrognosisZhengqiu Zhou, Connor J Kinslow, Peng Wang, et al.
Journal of Clinical Medicine|February 17, 2019
Clinical Features, Survival and Prognostic Factors of Glycogen-Rich Clear Cell Carcinoma (GRCC) of the Breast in the U.S. PopulationZhengqiu Zhou, Connor J Kinslow, Hanina Hibshoosh, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2010
Structural basis for the glucan phosphatase activity of Starch Excess4Craig W Vander Kooi, Adam O Taylor, Rachel M Pace, et al.
Elife|October 25, 2017
What's in a name?Michael D Schaller, Gary McDowell, André Porter, et al.
Plos One|September 3, 2011
Laforin, a dual specificity phosphatase involved in Lafora disease, is present mainly as monomeric form with full phosphatase activityVikas V Dukhande, Devin M Rogers, Carlos Romá-Mateo, et al.
Human Molecular Genetics|December 22, 2011
Laforin and malin knockout mice have normal glucose disposal and insulin sensitivityAnna A DePaoli-Roach, Dyann M Segvich, Catalina M Meyer, et al.
Epilepsy Research|July 25, 2018
A novel EPM2A mutation yields a slow progression form of Lafora diseaseMaria Adelaida Garcia-Gimeno, Pilar Natalia Rodilla-Ramirez, Rosa Viana, et al.
Epilepsy & Behavior : E&B|May 4, 2021
The 6th International Lafora Epilepsy Workshop: Advances in the search for a cureKia H Markussen, Jessica K A Macedo, María Machío, et al.
Pageof 13